An identity that still has to clear the same review as the copy.
Pharmaceutical brand identity for a product or therapeutic area: visual system, naming considerations and guidelines built with medical and regulatory review as a design constraint, not an afterthought applied to a finished identity.
A product identity in this sector has to work across packaging, a professional area, patient materials and every market the product launches in, each with its own review process and sometimes its own restrictions on colour, symbol or claim adjacent to the mark.
Brand strategy and positioning, the visual identity system, guidelines covering every application including regulated ones, and support through your medical, legal and regulatory review of the identity itself.
We work alongside your legal counsel throughout, designing within the constraints their trademark clearance produces so the identity that reaches market is one that has already cleared it, not one that has to be reworked after the fact.
The scope our pharmaceutical brand identity work has operated within.
The identity job differs by what is being branded. Pharmaceutical brand identity starts from that scope.
What comes up before commissioning a brand identity project.
No, trademark clearance runs through your legal counsel, not through us. We design within whatever naming and visual constraints that process produces, and we adjust direction if a mark runs into conflict partway through development, rather than treating the identity as fixed before clearance is complete.
Yes, and we design for that from the start whenever it is known to be needed — checking for obvious colour, symbol or naming sensitivities across your target markets, and building brand guidelines flexible enough to absorb local regulatory variation without the identity fracturing market by market.
Often, particularly where a colour, symbol or visual device could be read as implying a clinical claim rather than a design choice. We build that review time into the schedule from the outset, so it functions as a planned checkpoint rather than a late-stage surprise that delays launch.
Yes, this covers a product or therapeutic-area brand rather than the company as a whole. See corporate identity for the company-level identity that individual product brands typically sit inside, and how the two are kept visually and structurally distinct even when built by the same team.
Brand identity work pairs with naming and rollout. These are the related services.
A new product needing a distinct identity, or a therapeutic-area brand needing definition. Tell us the context and we will tell you how we would approach the pharmaceutical brand identity.